SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551986-19-000102
Filing Date
2019-08-08
Accepted
2019-08-08 16:41:36
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q innt630201910-q.htm 10-Q 1034898
2 EXHIBIT 31.1 ex311q22019.htm EX-31.1 16110
3 EXHIBIT 31.2 ex312q22019.htm EX-31.2 16140
4 EXHIBIT 32.1 ex321q22019.htm EX-32.1 9237
5 EXHIBIT 32.2 ex322q22019.htm EX-32.2 9310
  Complete submission text file 0001551986-19-000102.txt   5966094

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT innt-20190630.xml EX-101.INS 1175538
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT innt-20190630.xsd EX-101.SCH 46892
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT innt-20190630_cal.xml EX-101.CAL 55207
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT innt-20190630_def.xml EX-101.DEF 263725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT innt-20190630_lab.xml EX-101.LAB 653227
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT innt-20190630_pre.xml EX-101.PRE 379206
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37797 | Film No.: 191010158
SIC: 2834 Pharmaceutical Preparations